Global Health Data Exchange - Discover the World's Health Data

WHO European Region Bacterial Antimicrobial Resistance Burden Estimates 2019

Nav

General Info
Provider 
Institute for Health Metrics and Evaluation (IHME)
Geography 
Albania (ALB)
Andorra (AND)
Armenia (ARM)
Austria (AUT)
Azerbaijan (AZE)
Belarus (BLR)
Belgium (BEL)
Bosnia and Herzegovina (BIH)
Bulgaria (BGR)
Croatia (HRV)
Cyprus (CYP)
Czechia (CZE)
Denmark (DNK)
Estonia (EST)
Finland (FIN)
France (FRA)
Georgia (GEO)
Germany (DEU)
Greece (GRC)
Hungary (HUN)
Iceland (ISL)
Ireland (IRL)
Israel (ISR)
Italy (ITA)
Kazakhstan (KAZ)
Kyrgyzstan (KGZ)
Latvia (LVA)
Lithuania (LTU)
Luxembourg (LUX)
Malta (MLT)
Monaco (MCO)
Montenegro (MNE)
Netherlands (NLD)
North Macedonia (MKD)
Norway (NOR)
Poland (POL)
Portugal (PRT)
Republic of Moldova (MDA)
Romania (ROU)
Russian Federation (RUS)
San Marino (SMR)
Serbia (SRB)
Slovakia (SVK)
Slovenia (SVN)
Spain (ESP)
Sweden (SWE)
Switzerland (CHE)
Tajikistan (TJK)
Turkmenistan (TKM)
Türkiye (TUR)
Ukraine (UKR)
United Kingdom (GBR)
Uzbekistan (UZB)
View all
Coverage type 
Country
Time period covered 
01/2019 - 12/2019
Data type
Estimate
Summary 

Researchers at IHME and the University of Oxford produced estimates of deaths, disability-adjusted life years (DALYs), years lived with disability (YLDs), and years of life lost (YLLs) associated with and attributable to bacterial antimicrobial resistance (AMR) in 88 pathogen-drug combinations for 53 countries within the WHO European Region in 2019. A variety of data were gathered to inform these estimates, including multiple cause of death data, hospital discharges, minimally invasive tissue sampling, systematic literature reviews, and microbiology lab results from hospitals and national and multi-national surveillance systems, with a total of 471 million individual records or isolates and 7,585 study-location-years collected. These data informed 8 modelling components which were then combined with results from GBD 2019 to estimate the burden of AMR. Estimates were produced for two counterfactual scenarios: no infection and drug-susceptible infection.

Keywords 
Antibiotics, Bacterial skin diseases, Carbapenem, Cardiovascular and circulatory diseases, Cephalosporin, Chlamydia, Chloramphenicol, DALYs, Diarrhea, Digestive diseases, Drug resistance, E. coli, Endocarditis, Fluoroquinolone, GAS infection, GBS infection, Gonococcal infections, Haemophilus influenzae infection, Infectious diseases, Invasive nontyphoidal salmonella, Lower respiratory infections, MRSA infection, Meningitis, Meningococcal infection, Mortality, Musculoskeletal diseases, Pathogens, Penicillin, Peritonitis, Salmonella infections, Shigellosis, Streptococcus pneumoniae infection, Tuberculosis, Typhoid and paratyphoid fevers, Urinary tract infections, YLDs, YLLs
Related publications and visualizations 
The burden of bacterial antimicrobial resistance in the WHO European Region in 2019: a cross-country systematic analysis
GHDx Entry last modified on: Oct 25, 2024